可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]YlaHerttuala S, Alitalo K. Gene transfer as a tool to induce therapeutic vascular growth[J]. Nat Med, 2003, 9: 694-701.
[2]Lee RJ, Springer ML, BlancoBose WE, et al. VEGF gene delivery to myocardium: deleterious effects of unregulated expression[J]. Circulation, 2000, 102: 898-901.
[3]周 菲,秦永文,荆 清,等. 成年大鼠成肌细胞的原代培养[J]. 中华老年心脑血管病杂志, 2001, 3 :43-46.
[4]Ozawa CR, Banfi A, Glazer NL, et al. Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis[J]. J Clin Invest, 2004, 113(4):516-527.
[5]Suzuki K, Murtuza B, Smolenski RT, et al.Cell transplantation for the treatment of acute myocardial infarction using vascular endothelial growth factorexpressing skeletal myoblasts[J]. Circulation, 2001, 104(Suppl I):I207- I212.
[6]Menasche P. Myoblastbased cell transplantation[J]. Heart Fail Rev, 2003, 8(3):221-227.
[7]von Degenfeld G, Banfi A, Springer ML, et al. Myoblastmediated gene transfer for therapeutic angiogenesis and arteriogenesis[J]. Br J Pharmacol, 2003, 140(4):620-626.
[8]Germani A, Di Carlo A, Mangoni A, et al. Vascular endothelial growth factor modulates skeletal myoblast function[J]. Am J Pathol, 2003, 163(4):1417-1428.
[9]郝亚荣,李庚山,李建军,等. 血管内皮生长因子对培养内皮细胞合成一氧化氮的影响[J]. 心脏杂志,2002,14(3):186-188.